Tagged: Ralph Nixon

1

Phase 3 Alzheimer’s drug increases toxic beta amyloid in the brain — but still provides benefits

New insights into how a Phase III Alzheimer’s drug might work were among the advances in potential therapies targeting two abnormal brain proteins – beta amyloid and phosphorylated tau – that were reported today at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD 2009) in Vienna.